dMMR Market Analysis: Tumor-Agnostic Therapies Driving Future Growth
Mismatch Repair Deficiency (dMMR) emerges as a transformative biomarker highlighting disruptions in DNA error-correction mechanisms during cellular replication. When these protective systems malfunction, genetic aberrations proliferate, triggering genomic chaos and amplifying cancer development risks. This biomarker demonstrates particular significance across colorectal, endometrial, and...
0 0 Comentários 0 Compartilhamentos